Skip to main content

Enhancement of Healthy Personality Through Psychiatric Medication: The Influence of SSRIs on Neuroticism and Extraversion

Neuroethics volume 8, pages 127–137 (2015)Cite this article

Abstract

Selective serotonin reuptake inhibitors’ (SSRIs’) wide use, combined with the blurry limit between health and psychological illness, have led neuroscientists, clinicians and ethicists to envision the possibility of these medications’ use in non-clinical populations. This prospect has evoked ethical debates, which have often ignored the findings of the empirical literature. In this context, an evaluation of the empirical evidence for SSRIs’ personality enhancing effects is needed. The present paper examines SSRIs’ effects on healthy personality, including the Five Factor Model traits Neuroticism and Extraversion, as well as some of their facets: Angry Hostility, Impulsiveness, Vulnerability, Warmth, Gregariousness and Assertiveness. The review encompasses investigations in healthy humans, human clinical populations, as well as relevant animal studies. Emerging data raise the possibility that SSRIs, when used by people without a currently diagnosable mental disorder, may reduce some facets of Neuroticism, especially Angry Hostility. On the other hand, very limited support exists for an SSRI-driven change in other Neuroticism facets, such as Impulsiveness, in healthy humans. An increase in Extraversion (potentially, Warmth, Gregariousness, and, in some contexts, Assertiveness) is possible, but currently available evidence is only indirect. Future research is needed, both to clarify methodological ambiguities in existing studies, and to answer unaddressed questions, such as ones of the stability, predictors, moderators, dose- and context-dependency of the effects.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Notes

  1. The findings of the animal literature should not be automatically discounted as near-irrelevant, given the similarity between animal and human tests of some forms of impulsiveness (e.g., delay discounting) and the commonalities between animals’ and humans’ neurobiology of impulsivity [63]

References

  1. Kass, L. 2003. Beyond Therapy: Biotechnology and the Pursuit of Happiness. New York: Dana Press.

    Google Scholar 

  2. Fukuyama, F. 2003. Out Post-human Future: Consequences of the Biotechnology Revolution. London: Macmillan.

    Google Scholar 

  3. DeGrazia, D. 2005. Enhancement technologies and human identity. The Journal of Medicine and Philosophy 30(3): 261–283.

    Article  Google Scholar 

  4. Kramer, P. 1993. Listening to Prozac. New York: Penguin.

    Google Scholar 

  5. McRae, R.R., and P.T. Costa. 1987. Validation of the five factor model of personality across instruments and observers. Journal of Personality and Social Psychology 52: 81–90.

    Article  Google Scholar 

  6. Sahakian, B.J., and S. Morein-Zamir. 2011. Neuroethical issues in cognitive enhancement. Journal of Psychopharmacology (Oxford, England) 25(2): 197–204.

    Article  Google Scholar 

  7. Smith, M.E., and M.J. Farah. 2011. Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin 137(5): 717–741.

    Article  Google Scholar 

  8. Canli, T., Zhao, Z., Desmond, J., Kang, E., Gross, J. & Gabrieli, J. D. E. 2001. An fMRI study of personality influences on reactivity to emotional stimuli. Behavioral Neuroscience, 115 (1).

  9. Canli, T., Sivers, H., Whitfield, S. L., Gotlib, I. H., & Gabrieli, J. D. E. 2002. Amygdala response to happy faces as a function of extraversion. Science, 296(5576).

  10. Bagby, R.M., R.D. Levitan, S.H. Kennedy, A.J. Levitt, and R.T. Joffe. 1999. Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity. Psychiatry Research 86(3): 211–216.

    Article  Google Scholar 

  11. Du, L., D. Bakish, A.V. Ravindran, and P.D. Hrdina. 2002. Does fluoxetine influence major depression by modifying five-factor personality traits? Journal of Affective Disorders 71(1–3): 235–241.

    Article  Google Scholar 

  12. Tang, T.Z., R.J. Derubeis, S.D. Hollon, J. Amsterdam, R. Shelton, and B. Schalet. 2010. Personality change during depression treatment. Archives of General Psychiatry 66(12): 1322–1330.

    Article  Google Scholar 

  13. Jylhä, P., M. Ketokivi, O. Mantere, T. Melartin, M. Holma, H. Rytsälä, and E. Isometsä. 2012. Do antidepressants change personality?–A five-year observational study. Journal of Affective Disorders 142(1–3): 200–207. doi:10.1016/j.jad.2012.04.026.

    Article  Google Scholar 

  14. Chan, S.W.Y., R. Norbury, G.M. Goodwin, and C.J. Harmer. 2009. Risk for depression and neural responses to fearful facial expressions of emotion. The British Journal of Psychiatry : the Journal of Mental Science 194(2): 139–145.

    Article  Google Scholar 

  15. Norbury, R., M.J. Taylor, S. Selvaraj, S.E. Murphy, C.J. Harmer, and P.J. Cowen. 2009. Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology 206(2): 197–204.

    Article  Google Scholar 

  16. Murphy, S. E., Norbury, R., O’Sullivan, U., Cowen, P. J., & Harmer, C. J. (2009). Effect of a single dose of citalopram on amygdala response to emotional faces. The British journal of psychiatry: the journal of mental science, 194.

  17. Harmer, C. J,., Shelley, N. C., Cowen, P. J., & Goodwin, G. M. (2004). Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. American Journal of Psychiatry 161: 1256–1263.

  18. Harmer, C.J., C.E. Mackay, C.B. Reid, P.J. Cowen, and G.M. Goodwin. 2006. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biological Psychiatry 59(9): 816–820.

    Article  Google Scholar 

  19. Grady, C.L., H.R. Siebner, B. Hornboll, J. Macoveanu, O.B. Paulson, and G.M. Knudsen. 2013. Acute pharmacologically induced shifts in serotonin availability abolish emotion-selective responses to negative face emotions in distinct brain networks. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology 23(5): 368–378. doi:10.1016/j.euroneuro.2012.06.003.

    Article  Google Scholar 

  20. Di Simplicio, M., R. Norbury, A. Reinecke, and C.J. Harmer. 2014. Paradoxical effects of short-term antidepressant treatment in fMRI emotional processing models in volunteers with high neuroticism. Psychological Medicine 44(2): 241–252. doi:10.1017/S0033291713000731.

    Article  Google Scholar 

  21. Alvez-Neto, W.C., V.G. Guapo, F.G. Graeff, J.F.W. Deakin, and C.M. Del-Ben. 2010. Effect of escitalopram on the processing of emotional faces. Brazilian Journal of Medical and Biological Research 43(3): 285–289.

    Article  Google Scholar 

  22. Harmer, C.J., Z. Bhagwagar, D.I. Perrett, B.A. Völlm, P.J. Cowen, and G.M. Goodwin. 2003. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28(1): 148–152.

    Article  Google Scholar 

  23. Furlan, P.M., M.J. Kallan, T.T. Have, I. Lucki, and I. Katz. 2004. SSRIs do not cause affective blunting in healthy elderly volunteers. The American Journal of Geriatric Psychiatry 12(3): 323–330.

    Article  Google Scholar 

  24. Knorr, U., Vinberg, M., Mortensen, E. L., Winkel, P., Gluud, C., Wetterslev, J., Gether, U., et al. (2012). Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a Randomized Trial. PloS one, 7(2).

  25. Simmons, J.G., and N.B. Allen. 2011. Mood and personality effects in healthy participants after chronic administration of sertraline. Journal of Affective Disorders 134(1–3): 377–385.

    Article  Google Scholar 

  26. Gelfin, Y., M. Gorfine, and B. Lerer. 1998. Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. The American Journal of Psychiatry 155(2): 290–292.

    Google Scholar 

  27. Carrillo, M., L.A. Ricci, G.A. Coppersmith, and R.H. Melloni. 2009. The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies. Psychopharmacology 205(3): 349–368.

    Article  Google Scholar 

  28. Fava, M., J. Alpert, A.A. Nierenberg, N. Ghaemi, R. O’Sullivan, et al. 1996. Fluoxetine treatment of anger attacks: a replication study. Annals of Clinical Psychiatry 8: 52.

    Article  Google Scholar 

  29. Castrogiovanni, P., Di Muro, A. & Meremmani, I. (1992). Fluoxetine reduces aggressive behavior in depressive outpatients. New Trends in Experimental and Clinical Psychiatry, 8 (2).

  30. Heiligenstein, J.H., C.M. Beasley, and J.H. Potvin. 1993. Fluoxetine not associated with increased aggression in controlled clinical trials. International Clinical Psychopharmacology 8: 277–280.

    Article  Google Scholar 

  31. Cherek, D.R., S.D. Lane, C.J. Pietras, and J.L. Steinberg. 2002. Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder. Psychopharmacology 159(3): 266–274. doi:10.1007/s002130100915.

    Article  Google Scholar 

  32. Coccaro, E.F., R.J. Lee, and R.J. Kavoussi. 2009. A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. The Journal of Clinical Psychiatry 70(5): 653–662. doi:10.4088/JCP.08m04150.

    Article  Google Scholar 

  33. Salzman, C., A.N. Wolfson, A. Schaltzberg, J. Looper, R. Henke, M. Albanese, J. Schwarz, and E. Miyawaki. 1995. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology 15(1): 23–29.

    Article  Google Scholar 

  34. New, A.S., M.S. Buchsbaum, E.A. Hazlett, M. Goodman, H.W. Koenigsberg, J. Lo, L. Iskander, et al. 2004. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology 176(3–4): 451–458.

    Article  Google Scholar 

  35. Coccaro, E.F., and R.J. Kavoussi. 1997. Fluoxetine and impulsive-aggressive behavior inpersonality-disordered subjects. Archives of General Psychiatry 54: 1081–1088.

    Article  Google Scholar 

  36. Rinne, T., W. van den Brink, L. Wouters, and R. van Dyck. 2002. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. The American Journal of Psychiatry 159(12): 2048–2054.

    Article  Google Scholar 

  37. Lee, R., R.J. Kavoussi, and E.F. Coccaro. 2008. Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers. International Clinical Psychopharmacology 23(6): 337–341. doi:10.1097/YIC.0b013e32830fbdd2.

    Article  Google Scholar 

  38. Knutson, B., O.M. Wolkowitz, S.W. Cole, T. Chan, E.A. Moore, R.C. Johnson, J. Terpstra, et al. 1998. Selective alteration of personality and social behavior by serotonergic intervention. The American Journal of Psychiatry 155(3): 373–379.

    Article  Google Scholar 

  39. Kamarck, T.W., R.F. Haskett, M. Muldoon, J.D. Flory, B. Anderson, R. Bies, B. Pollock, et al. 2009. Citalopram intervention for hostility: results of a randomized clinical trial. Journal of Consulting and Clinical Psychology 77(1): 174–188. doi:10.1037/a0014394.

    Article  Google Scholar 

  40. McCloskey, M.S., M.E. Berman, D.J. Echevarria, and E.F. Coccaro. 2009. Effect of acute alcohol intoxication and paroxetine on aggression in men. Alcoholism: Clinical and Experimental Research 33(4): 581–590.

    Article  Google Scholar 

  41. Berman, M.E., M.S. McCloskey, J.R. Fanning, J.A. Schumacher, and E.F. Coccaro. 2009. Serotonin augmentation reduces response to attack in aggressive individuals. Psychological Science 20(6): 714–720. doi:10.1111/j.1467-9280.2009.02355.x.

    Article  Google Scholar 

  42. Ekselius, L., and L. Von Knorring. 1999. Changes in personality traits during treatment with sertraline or citalopram. The British Journal of Psychiatry 174(5): 444–448.

    Article  Google Scholar 

  43. Drueke, B., M. Boecker, S. Schlaegel, O. Moeller, C. Hiemke, S. Gauggel, and G. Gru. 2010. Serotonergic modulation of response inhibition and re-engagement ? Results of a study in healthy human volunteers. Human Psychopharmacology 25: 472–480.

    Article  Google Scholar 

  44. Chamberlain, S.R., U. Müller, A.D. Blackwell, L. Clark, T.W. Robbins, and B.J. Sahakian. 2006. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311(5762): 861–863.

  45. Nandam, L.S., R. Hester, J. Wagner, T.D.R. Cummins, K. Garner, A.J. Dean, B.N. Kim, et al. 2011. Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biological Psychiatry 69(9): 902–904.

    Article  Google Scholar 

  46. Almeida, S., D.C. Glahn, S.V. Argyropoulos, and S. Frangou. 2010. Acute citalopram administration may disrupt contextual information processing in healthy males. European Psychiatry : the Journal of the Association of European Psychiatrists 25(2): 87–91.

    Article  Google Scholar 

  47. Del-Ben, C.M., J.F.W. Deakin, S. McKie, N.A. Delvai, S.R. Williams, R. Elliott, M. Dolan, et al. 2005. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 30(9): 1724.

    Article  Google Scholar 

  48. Bizot, J., C. Le Bihan, A.J. Puech, M. Hamon, and M. Thiébot. 1999. Serotonin and tolerance to delay of reward in rats. Psychopharmacology 146(4): 400–412.

    Article  Google Scholar 

  49. Evenden, J.L., and C.N. Ryan. 1996. The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology 128(2): 161–170.

    Article  Google Scholar 

  50. Wolff, M.C., and J.D. Leander. 2002. Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon. Neuropsychopharmacology 27(3): 421–429.

    Article  Google Scholar 

  51. Garcia-Leal, C., C.M. Del-Ben, F.M. Leal, F.G. Graeff, and F.S. Guimarães. 2010. Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation. Journal of Psychopharmacology (Oxford, England) 24(5): 683–694.

    Article  Google Scholar 

  52. Figgitt, D.P., and K.J. McClellan. 2000. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. Drugs 60(4): 925–954.

    Article  Google Scholar 

  53. Sareen, L., and M. Stein. 2000. A review of the epidemiology and approaches to the treatment of social anxiety disorder. Drugs 59(3): 497–509.

    Article  Google Scholar 

  54. Lightowler, S., G.A. Kennett, I.J. Williamson, T.P. Blackburn, and I.F. Tulloch. 1994. Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacology, Biochemistry, and Behavior 49(2): 281–285.

    Article  Google Scholar 

  55. Raleigh, M.J., M.T. McGuire, G.L. Brammer, D.B. Pollack, and A. Yuwiler. 1991. Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Research 559(2): 181–190.

    Article  Google Scholar 

  56. Knutson, Brian, J. Panksepp, and D. Pruitt. 1996. Effects of fluoxetine on play dominance in juvenile rats. Aggressive Behavior 22(4): 297–307.

    Article  Google Scholar 

  57. Tse, W.S., and A.J. Bond. 2002. Serotonergic intervention affects both social dominance and affiliative behaviour. Psychopharmacology 161(3): 324–330.

    Article  Google Scholar 

  58. Repantis, D., P. Schlattmann, O. Laisney, and I. Heuser. 2008. Antidepressants for neuroenhancement in healthy individuals: a systematic review. Poiesis and Praxis 6(3–4): 139–174.

    Google Scholar 

  59. Serretti, A., R. Calati, A. Goracci, M. Di Simplicio, P. Castrogiovanni, and D. De Ronchi. 2010. Antidepressants in healthy subjects: what are the psychotropic/psychological effects? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology 20(7): 433–453.

    Article  Google Scholar 

  60. Hinkelmann, K., L. Dragoi, J. Gompf, C. Muhtz, C. Demiralay, A. Yassouridis, K. Wiedemann, et al. 2010. Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype. Psychiatry Research 177(3): 354–357.

    Article  Google Scholar 

  61. Bhagwagar, Z., P.J. Cowen, G.M. Goodwin, and C.J. Harmer. 2004. Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. The American Journal of Psychiatry 161(1): 166–168.

    Article  Google Scholar 

  62. Harmer, C.J. 2008. Serotonin and emotional processing: does it help explain antidepressant drug action? Neuropharmacology 55(6): 1023–1028.

    Article  Google Scholar 

  63. Winstanley, C. A. (2011). The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. British journal of pharmacology, 164(4).

  64. Fournier, J.C., DeRubeis, R.J., Hollon, S.D., Dimidjian, S., Amsterdam, J.D., Shelton, R.C. & Fawcett, J. (2010). Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA, 303 (1).

  65. Khan, A., Leventhal, R.M., Khan, S.R., Brown, W.A. (2002). Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration data-base. J Clin Psychopharmacol, 22 (1).

  66. Kirsch, I., B.J. Deacon, T.B. Huedo-Medina, A. Scoboria, T.J. Moore, and B.T. Johnson. 2008. Initial severity and anti-depressant benefits: a meta-analysis submitted to the food and drug administration. PLoS Medicine 5(2): e45.

    Article  Google Scholar 

  67. Button, K.S., J.P.A. Ioannidis, C. Mokrysz, B.A. Nosek, J. Flint, E.S.J. Robinson, and M.R. Munafo. 2013. Power failure: why small sample size undermines the reliability of neuroscience. Nature Reviews Neuroscience 14(5): 365–376.

    Article  Google Scholar 

Download references

Acknowledgments

I wish to thank Martha Farah, Rob DeRubeis, Geoff Goodwin and Teresa Pegors for their invaluable feedback about this project.

Author information

Authors and Affiliations

  1. Psychology Department, University of Pennsylvania, 3720 Walnut Street, Room B51, Philadelphia, PA, 19104, USA

    Irena Ilieva

  2. Center for Neuroscience and Society, University of Pennsylvania, Philadelphia, PA, USA

    Irena Ilieva

Authors
  1. Irena Ilieva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irena Ilieva.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ilieva, I. Enhancement of Healthy Personality Through Psychiatric Medication: The Influence of SSRIs on Neuroticism and Extraversion. Neuroethics 8, 127–137 (2015). https://doi.org/10.1007/s12152-014-9226-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12152-014-9226-z

Keywords

  • Antidepressant
  • SSRI
  • Personality
  • Neuroticism
  • Aggression
  • Hostility